NCT02724254 - A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients | Biotech Hunter

Enrollment

218

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

May 31, 2018

Study Completion Date

July 31, 2018

Conditions

Condyloma

Interventions

DRUG

AP611074 5% gel

DRUG

AP611074 matching placebo

Trial Locations (12)

Anaconda Invesigational Site, Buenos Aires

Anaconda Investigational Site, Buenos Aires

Anaconda Investigational Site, Córdoba

Anaconda Investigational Site, Mendoza

Anaconda Investigational Site, Sante Fe

Anaconda Investigational Site, Concepción

Anaconda Investigational Site, Santiago

Anaconda Investigational Site, Cumbayá

Anaconda Investigational Site, Guayaquil

Anaconda Investigational Site, Quito

Anaconda Investigational Site, Belgrade

Anaconda Investigational Site, Novi Sad